Subscribe
The latest psychology and neuroscience discoveries.
My Account
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Psychopharmacology
  • Neuroscience
  • About
No Result
View All Result
PsyPost
PsyPost
No Result
View All Result
Home Exclusive Social Psychology Business

New study links mindfulness meditation and psychedelic use to positive leadership outcomes at work

by Eric W. Dolan
August 14, 2023
in Business, Meditation, Psychedelic Drugs
Share on TwitterShare on Facebook
Stay on top of the latest psychology findings: Subscribe now!

Mindfulness meditation and psychedelic use might produce positive leadership outcomes among business managers, according to new research published in Frontiers in Psychology. The preliminary study sheds light on the potential impact of mindfulness meditation and psychedelic use on leadership development.

The study was motivated by anecdotal reports of individuals using altered states for peak performance and leadership growth, with a specific focus on mindfulness meditation and psychedelics like LSD. Despite the increasing popularity of these interventions, there was limited empirical data on their effects, particularly regarding psychedelics and their potential influence on leadership development.

Previous research had shown that mindfulness meditation had diverse effects on outcomes related to leadership, such as stress reduction, sleep, creativity, and emotion regulation. However, previous studies were often limited by small sample sizes and potential self-selection biases. Similarly, while some research suggested that psychedelics, particularly in safe and supportive contexts, could impact psychological health, creative thinking, and interpersonal attitudes, there was little research on their connection to leadership outcomes.

“There’s been a fair amount of research on how mindfulness meditation and psychedelic substances may impact mental health. Yet there is relatively little empirical data on how these interventions, especially psychedelics, might affect leadership development,” said Otto Simonsson, a postdoctoral researcher at Karolinska Institutet’s Department of Clinical Neuroscience and the corresponding author of the new study.

To address these gaps in the literature, the researchers used Prolific Academic to recruit two samples of participants: 4,867 U.S. adults and 4,865 U.K. adults. This platform offers representative samples of the U..S and U.K. populations based on factors like sex, age, and ethnicity. The study description did not mention psychedelics to avoid bias in self-selection.

These participants provided demographic information, including age, gender, educational attainment, religiosity, political affiliation, and management role. They were asked about their mindfulness meditation experiences and experiences with psychedelic substances.

The participants were asked to provide written responses about how mindfulness meditation or psychedelic experiences influenced their leadership. These responses were coded independently by two researchers for themes such as no impact, positive impact, or negative impact on leadership.

Of the 3,150 participants who held a management position, a significant portion had tried mindfulness meditation (43.6% of the management sample) and a smaller portion had tried psychedelics (17.7% of the management sample). Approximately 10% of the management sample had tried both mindfulness meditation and psychedelics.

Regarding the perceived impact of these practices on leadership, 70.9% of the responses related to mindfulness meditation described a positive impact, 28.8% described no impact, and only a very small fraction (0.2%) indicated a negative impact. Similarly, for responses about psychedelics and leadership, 40.6% described a positive impact, 58.0% indicated no impact, and a small percentage (1.4%) noted a negative impact.

The researchers also conducted a thematic analysis of the written descriptions provided by participants who had experienced either mindfulness meditation or psychedelic use to identify broader patterns and themes in the qualitative data. This resulted in four main themes related to positive impacts.

“Although the findings should be interpreted in light of the study’s limitations, the main takeaway from the study, I think, is that mindfulness meditation and psychedelic use may produce comparable and also complementary effects on leadership at work,” Simonsson told PsyPost.

Many participants reported that mindfulness meditation and/or psychedelic substances had a positive impact on their wellbeing and health. They described how it helped them manage stress, anxiety, and emotions, contributing to better sleep and overall health. This enhanced their resilience and effectiveness as leaders.

Participants noted increased presence and awareness resulting from mindfulness meditation and/or psychedelic substances. This contributed to more effective leadership as they became more attuned to their own actions, thoughts, and emotions.

Mindfulness meditation and/or psychedelic use was associated with enhanced creativity, increased productivity, and improved problem-solving skills. Respondents noted increased cognitive function and better decision-making, contributing to better leadership performance.

Finally, many participants highlighted how mindfulness meditation and/or psychedelic substances had influenced their interpersonal attitudes and behaviors. Many reported greater empathy, compassion, and patience. They often mentioned adopting a more egalitarian and understanding attitude toward coworkers, leading to stronger bonds and a sense of unity within teams.

The researchers were unable to identify consistent or meaningful patterns in the responses that were coded as having a negative impact due to the low number of responses in the negative impact category. But they noted that some participants reported difficulties focusing, feeling unwell, or experiencing after-effects that negatively affected their work performance.

While the study provides valuable insights into the potential positive impacts of mindfulness meditation and psychedelic use on leadership development, some limitations should be taken into consideration when interpreting the findings. For example, the study did not collect detailed information about participants’ mindfulness meditation practices or psychedelic experiences, such as dosage, frequency, or specific techniques used. These factors could significantly influence the outcomes observed. Additionally, the study’s cross-sectional design prevents the establishment of causal relationships between mindfulness meditation, psychedelic use, and leadership outcomes.

“While the findings in this study should be considered preliminary due to the limitations of the research design, the results suggest that mindfulness meditation and psychedelic use may produce comparable and also complementary effects on leadership at work,” the researchers concluded. “If replicated in future studies with more rigorous research designs (e.g., randomized controlled trials), such findings could lead to the development of novel training programs that combine both mindfulness meditation and psychedelics to improve leadership at work.”

The study, “Altered states of leadership: mindfulness meditation, psychedelic use, and leadership development“, was authored by Otto Simonsson, Cecilia U. D. Stenfors, Simon B. Goldberg, Peter S. Hendricks, and Walter Osika.

TweetSendScanShareSendPin13ShareShareShareShareShare

RELATED

Psychedelic compound blurs boundary between self and others in the brain, study finds
Ayahuasca

Psychedelic compound blurs boundary between self and others in the brain, study finds

July 2, 2025

A recent study found that a DMT/harmine formulation blurs the brain’s distinction between self and other faces, disrupting self-referential processing while preserving recognition of familiar faces, suggesting a neural basis for psychedelic-induced ego dissolution.

Read moreDetails
Researchers identify neural mechanism behind memory prioritization
MDMA

New study reveals how MDMA rewires serotonin and oxytocin systems in the brain

June 30, 2025

Researchers found that MDMA reduces anxiety and enhances social behavior in zebrafish by altering key neurochemical systems. The drug suppressed serotonin signaling, boosted oxytocin receptor expression, and modulated brain signaling proteins involved in emotional regulation.

Read moreDetails
Regular psychedelic users exhibit different brain responses to self-related thoughts, study finds
Neuroimaging

Regular psychedelic users exhibit different brain responses to self-related thoughts, study finds

June 28, 2025

A new study suggests that regular users of psychedelics may process self-related thoughts differently at both psychological and brain levels, revealing altered patterns of brain activity during self-reflection compared to non-users who intend to try psychedelics.

Read moreDetails
Psychedelic use linked to increased risk of unusual visual experiences
Ayahuasca

Study links moderate awe in psychedelic ayahuasca journeys to better well-being

June 21, 2025

A new study published in the Journal of Psychoactive Drugs suggests that while awe can be transformative during ayahuasca retreats, there’s a limit. Experiences marked by excessive vastness were linked to lower well-being, challenging assumptions about awe’s universal benefits.

Read moreDetails
About 8% of psychedelic users report inappropriate sexual contact by guides
Psychedelic Drugs

Study links psychedelic use in illegal settings to increased psychotic and manic symptoms

June 18, 2025

New research suggests that naturalistic psychedelic use may worsen psychotic and manic symptoms when used in illegal settings. People with schizophrenia or bipolar I disorder appeared especially vulnerable to these effects, highlighting the importance of context and psychiatric background.

Read moreDetails
Some dark personality traits may help buffer against depression, new psychology research suggests
Mental Health

Psilocybin-assisted therapy linked to reduced depression in people with bipolar disorder, small study finds

June 17, 2025

A pilot study involving psilocybin-assisted therapy found possible antidepressant effects for people with bipolar II disorder. The treatment appeared well-tolerated, with no signs of mania or psychosis, offering cautious optimism for future bipolar depression research.

Read moreDetails
Psilocybin from “magic” mushrooms weakens the brain’s response to angry faces
Addiction

Single-dose psilocybin therapy shows promise for reducing alcohol consumption

June 15, 2025

Early results from a pilot study indicate that psilocybin-assisted therapy could be linked to lower alcohol consumption and improved psychological outcomes, though larger controlled trials are needed to determine whether the psilocybin itself is responsible for these changes.

Read moreDetails
Psilocybin appears to have a uniquely powerful relationship with nature relatedness
Neuroimaging

Psilocybin induces large-scale brain network reorganization, offering insights into the psychedelic state

June 14, 2025

A new study using high-resolution EEG reveals that psilocybin dramatically alters brain connectivity in rats. The psychedelic induced dose-dependent changes in network organization, disrupting normal patterns of neural communication and suggesting rodents may be viable models for studying altered consciousness.

Read moreDetails

SUBSCRIBE

Go Ad-Free! Click here to subscribe to PsyPost and support independent science journalism!

STAY CONNECTED

LATEST

Hispanic adolescents experience later sleep timing and greater social jet lag than peers, study finds

Student loan debt doesn’t deter civic engagement — it may actually drive it, new research suggests

Understanding “neuronal ensembles” could revolutionize addiction treatment

Not bothered by celebrity infidelity? This psychological trait might be why

Genetic factors may influence how well exercise buffers against childhood trauma

Tips for parents in talking with your kids about your partner’s mental illness

Subjective cognitive struggles strongly linked to social recovery in depression

New research suggests the conservative mental health advantage is a myth

         
       
  • Contact us
  • Privacy policy
  • Terms and Conditions
[Do not sell my information]

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy